Designing the Future Through Patient-Based Drug Development

Join us for our first scientific conference dedicated to generating safer and more effective treatments, while reducing animal testing.

Programme:

09:30 Walk in

10:00 Word of welcome, short update on Ombion, Prof. Daniela Salvatori, Ombion

10:15 Sneak Preview of the Ombion on-site centre and labs, Dr. Renée Moerkens, Dr. Tijmen Booij, Dr. Valentin Salamone, Ombion

10:30 Keynote: Bridging policy and science, Bas de Waard MSc, TPI LVVN

11:00 Industry perspective: barriers and opportunities, Giel Hendriks, Toxys, Jos Joore, Mimetas, Paul Carmichael, Unilever

12:00 Lunch break, poster time

13:00 Transition project ALS: understanding the contribution of skeletal muscle to ALS using 3D tissue-engineered skeletal muscle and microfluidics, Dr. Domino Schlegel, UMC Utrecht

13:30 Transition project Osteoarthritis & Rheumatoid Arthrosis: innovations in animal-free osteoarthritis and rheumatoid arthritis biomedical translation, Prof. Dr. Tim Welting, Maastricht UMC, Bringing pain into a dish: iPSC-derived sensory neuron models for osteoarthritis, Prof. Dr. Niels Eijkelkamp, UMC Utrecht

14:00 Transition project Asthma & COPD: patient-based models of endotypes of asthma and COPD, Prof. Dr. Gerard H. Koppelman, UMCG, Dr. Anne van der Does, LUMC

14:30 Transition project Cystic Fibrosis: building automated, patient-Derived Cell Model Pipelines for Cystic Fibrosis, Lara Zaidi MSc, UMC Utrecht, and Domenique Zomer, Cystic Fibrosis Stichting

15:00 Break, poster time

15:30 Validation and Qualification of NAMs towards Regulatory Acceptance and Widespread Adoption, Dr. Danilo Tagle, expert on NAMs, former Director of the Office of Special Initiatives, National Institutes of Health

16:00 Better predictive research for patient needs, Lisette Krul, Samenwerkende GezondheidsFondsen

16:15 Barriers and opportunities of regulatory innovation, Prof. Dr. Anne Kienhuis, RIVM

16:30 Reflections & Takeaways

16:40 Drinks

17:30 End